Family-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents: protocol for a randomised clinical trial (the TECTO trial).

Cognitive behavioural therapy (CBT) is the recommended first-line treatment for children and adolescents with obsessive-compulsive disorder (OCD), but evidence concerning treatment-specific benefits and harms compared with other interventions is limited. Furthermore, high risk-of-bias in most trials prevent firm conclusions regarding the efficacy of CBT. We investigate the benefits and harms of family-based CBT (FCBT) versus family-based psychoeducation and relaxation training (FPRT) in youth with OCD in a trial designed to reduce risk-of-bias. This is an investigator-initiated, independently funded, single-centre, parallel group superiority randomised clinical trial (RCT). Outcome assessors, data managers, statisticians, and conclusion drawers are blinded. From child and adolescent mental health services we include patients aged 8-17 years with a primary OCD diagnosis and an entry score of ≥16 on the Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS). We exclude patients with comorbid illness contraindicating trial participation; intelligence quotient < 70; or treatment with CBT, PRT, antidepressant or antipsychotic medication within the last 6 months prior to trial entry. Participants are randomised 1:1 to the experimental intervention (FCBT) versus the control intervention (FPRT) each consisting of 14 75-min sessions. All therapists deliver both interventions. Follow-up assessments occur in week 4, 8 and 16 (end-of-treatment). The primary outcome is OCD symptom severity assessed with CY-BOCS at end-of-trial. Secondary outcomes are quality-of-life and adverse events. Based on sample size estimation, a minimum of 128 participants (64 in each intervention group) are included. In our trial design we aim to reduce risk-of-bias, enhance generalisability, and broaden the outcome measures by: 1) conducting an investigator-initiated, independently funded RCT; 2) blinding investigators; 3) investigating a representative sample of OCD patients; 3) using an active control intervention (FPRT) to tease apart general and specific therapy effects; 4) using equal dosing of interventions and therapist supervision in both intervention groups; 5) having therapists perform both interventions decided by randomisation; 6) rating fidelity of both interventions; 7) assessing a broad range of benefits and harms with repeated measures. The primary study limitations are the risk of missing data and the inability to blind participants and therapists to the intervention. ClinicalTrials.gov : NCT03595098, registered July 23, 2018

Alimentação e ecomorfologia de duas espécies de piranhas (Characiformes: Characidae) do lago de Viana, estado do Maranhão, Brasil Feeding and ecomorphology of two species of piranhas (Characiformes: Characidae) from the Viana Lake, Maranhão state, Brazil

Serrasalmus aff. brandtii e Pygocentrus nattereri são duas espécies de piranhas comuns no Lago de Viana, um lago formado a partir das inundações do Rio Pindaré, tributário da margem esquerda do Rio Mearim. Uma amostra composta por 249 exemplares destas espécies foi estudada a fim de identificar a composição da dieta e as estratégias alimentares empregadas pelas duas. Os peixes foram coletados trimestralmente durante um ano, entre março de 1998 e março de 1999, usando redes de emalhar e tarrafas. A composição qualitativa da dieta foi analisada com uso do método de freqüência de ocorrência. As estratégias alimentares empregadas pelas espécies foram inferidas através do método gráfico de Costello (1990), modificado por Amundsen et al. (1996). Os resultados indicaram que peixes foi o item encontrado com maior freqüência nos estômagos de ambas as espécies, seguido de matéria vegetal, com maior participação na dieta de P. nattereri. Os recursos peixes e vegetais tenderam a apresentar relações inversas quando comparados com as diferentes classes de comprimento. A análise gráfica da dieta de P. nattereri e S. aff. brandtii sugere que a maioria dos indivíduos utiliza vários recursos simultaneamente. Uma análise multivariada de índices ecomorfológicos indicou que as espécies são segregadas com relação à habilidade natatória, posição ocupada na coluna d'água e tamanho relativo das presas.<br>Serrasalmus aff. brandtii and Pygocentrus nattereri are two species of piranhas, both common in the Viana Lake, which is formed by the flooding waters of the Pindaré River, a tributary of the left bank of the Mearim River. A sample composed of 249 specimens of these species was studied in order to identify diet composition and feeding strategies employed by the two species. The piranhas were captured thrimonthly, during one year from March 1998 to March 1999 using gill and fishing nets of different mesh sizes. The qualitative composition of the diet was analysed through the frequency of occurrence method. The feeding strategies employed by the piranhas were inferred using the graphic method of Costello (1990), modified by Amundsen et al. (1996). The results indicated that fish was the main food item in the stomach contents of the two species, followed by plant material, more in the P. nattereri. Fish and plant material showed different relationships in relation to piranhas's length classes. The graphic analysis of the feeding strategies employed by P. nattereri and S. aff. brandtii suggest a generalist habit, wide width niche with strong participation of the within-phenotype component, which indicated that the majority of individuals of these species use several resources simultaneously. A multivariate analysis of the ecomorphological index indicated that the species are discriminated by swimming ability, water column position and relative prey size

Range expansion of the small spruce bark beetle Ips amitinus: a newcomer in northern Europe

201

Vorapaxar in the secondary prevention of atherothrombotic events

Item does not contain fulltextBACKGROUND: Thrombin potently activates platelets through the protease-activated receptor PAR-1. Vorapaxar is a novel antiplatelet agent that selectively inhibits the cellular actions of thrombin through antagonism of PAR-1. METHODS: We randomly assigned 26,449 patients who had a history of myocardial infarction, ischemic stroke, or peripheral arterial disease to receive vorapaxar (2.5 mg daily) or matching placebo and followed them for a median of 30 months. The primary efficacy end point was the composite of death from cardiovascular causes, myocardial infarction, or stroke. After 2 years, the data and safety monitoring board recommended discontinuation of the study treatment in patients with a history of stroke owing to the risk of intracranial hemorrhage. RESULTS: At 3 years, the primary end point had occurred in 1028 patients (9.3%) in the vorapaxar group and in 1176 patients (10.5%) in the placebo group (hazard ratio for the vorapaxar group, 0.87; 95% confidence interval [CI], 0.80 to 0.94; P<0.001). Cardiovascular death, myocardial infarction, stroke, or recurrent ischemia leading to revascularization occurred in 1259 patients (11.2%) in the vorapaxar group and 1417 patients (12.4%) in the placebo group (hazard ratio, 0.88; 95% CI, 0.82 to 0.95; P=0.001). Moderate or severe bleeding occurred in 4.2% of patients who received vorapaxar and 2.5% of those who received placebo (hazard ratio, 1.66; 95% CI, 1.43 to 1.93; P<0.001). There was an increase in the rate of intracranial hemorrhage in the vorapaxar group (1.0%, vs. 0.5% in the placebo group; P<0.001). CONCLUSIONS: Inhibition of PAR-1 with vorapaxar reduced the risk of cardiovascular death or ischemic events in patients with stable atherosclerosis who were receiving standard therapy. However, it increased the risk of moderate or severe bleeding, including intracranial hemorrhage. (Funded by Merck; TRA 2P-TIMI 50 ClinicalTrials.gov number, NCT00526474.)